Does PALBOCICLIB Cause Metastases to lung? 258 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 258 reports of Metastases to lung have been filed in association with PALBOCICLIB (Ibrance). This represents 0.3% of all adverse event reports for PALBOCICLIB.
258
Reports of Metastases to lung with PALBOCICLIB
0.3%
of all PALBOCICLIB reports
33
Deaths
47
Hospitalizations
How Dangerous Is Metastases to lung From PALBOCICLIB?
Of the 258 reports, 33 (12.8%) resulted in death, 47 (18.2%) required hospitalization, and 12 (4.7%) were considered life-threatening.
Is Metastases to lung Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 258 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Metastases to lung?
LETROZOLE (703)
RIBOCICLIB (649)
CAPECITABINE (616)
BEVACIZUMAB (578)
PACLITAXEL (563)
FULVESTRANT (560)
EVEROLIMUS (522)
TRASTUZUMAB (458)
DOCETAXEL (415)
FLUOROURACIL (375)
Which PALBOCICLIB Alternatives Have Lower Metastases to lung Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID